Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides

January 3, 2024

https://www.globenewswire.com/news-release/2024/01/03/2803392/0/en/Sanara-MedTech-Inc-Announces-Exclusive-License-Agreement-for-Patented-Collagen-Peptides.html

FORT WORTH, TX, Jan. 03, 2024 (GLOBE NEWSWIRE) — Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ:SMTI), announced today that is has signed an exclusive license agreement with Tufts University (“Tufts”) to develop and commercialize patented technology covering 18 unique collagen peptides.

Read more at globenewswire.com

Related news for (SMTI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.